Fundraising Fox
Medyria
not stated, CH · 6 known investors
Find your way into Medyria
Sign up to see every warm intro you have to Medyria
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Medyria team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Medyria addresses the diagnosis of angina pectoris, focusing on coronary conditions such as Coronary Artery Disease (CAD) and Non-Obstructive Coronary Artery Disease (NOCAD) linked to coronary microvascular dysfunction. The company positions itself around cardiovascular diagnostics where standard tests fail to identify NOCAD and CMD patients in time.
Investors · 6
Also in the syndicate · 4
Funding
SEC filings, press & company announcements- Undisclosed amountSeries BMar 2023
Yellowstone Holding AG (lead), EFI-Lake Geneva Ventures, Start Angels Network, Zürcher Kantonalbank
Source ↗ - Undisclosed amountSeries BJan 2023
Yellowstone Holding AG (lead), EFI-Lake Geneva Ventures, Start Angels Network, Zürcher Kantonalbank
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
Frequently asked questions
- What does Medyria do?
- Medyria addresses the diagnosis of angina pectoris, focusing on coronary conditions such as Coronary Artery Disease (CAD) and Non-Obstructive Coronary Artery Disease (NOCAD) linked to coronary microvascular dysfunction. The company positions itself around cardiovascular diagnostics where standard tests fail to identify NOCAD and CMD patients in time.
- Who are Medyria's investors?
- Medyria's investors include StartAngels Network, Venture Kick.
- Where is Medyria headquartered?
- Medyria is headquartered in not stated, CH.